A study comparing a new topical gel formulation of oxybutynin to placebo has confirmed its efficacy and tolerability for treating overactive bladder. New formulations of oxybutynin have been ...

22, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company), the Company developing a new class of synthetic anti-infectives, today announced the dosing ...

A startup business in Wimborne has developed the world’s first CBD gel to gain NSF certification, meaning it can be used by ...

Recce Pharmaceuticals Ltd (ASX:RCE) has seen its share price move up more than 1% on Tuesday’s news that the company successfully dosed all 30 participants in its Phase II clinical trial of a gel to ...

Recently, a combination hormonal topical gel has shown promise by suppressing sperm production in a shorter amount of time ...